MENU
+Compare
TNYA
Stock ticker: NASDAQ
AS OF
Apr 3, 04:59 PM (EDT)
Price
$0.52
Change
-$0.05 (-8.77%)
Capitalization
92.01M

TNYA Tenaya Therapeutics Forecast, Technical & Fundamental Analysis

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease... Show more

TNYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for TNYA with price predictions
Apr 02, 2025

TNYA in +8.92% Uptrend, advancing for three consecutive days on March 17, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TNYA advanced for three days, in of 178 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TNYA's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for TNYA just turned positive on March 14, 2025. Looking at past instances where TNYA's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

TNYA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TNYA as a result. In of 54 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TNYA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.991) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. TNYA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TNYA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TNYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

TNYA is expected to report earnings to fall 24.61% to -21 cents per share on May 07

Tenaya Therapeutics TNYA Stock Earnings Reports
Q1'25
Est.
$-0.21
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.07
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.02
The last earnings report on March 10 showed earnings per share of -28 cents, beating the estimate of -31 cents. With 1.39M shares outstanding, the current market capitalization sits at 92.01M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
171 Oyster Point Boulevard
Phone
+1 650 825-6990
Employees
140
Web
https://www.tenayatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNSTY38.480.66
+1.75%
London Stock Exchange Ltd.
SRNW0.12N/A
+1.67%
Stratos Renewables Corp.
SKFRY20.480.24
+1.19%
AB SKF
GLGDF1.19-0.02
-1.65%
GoGold Resources, Inc.
AJINY39.85-0.88
-2.16%
Ajinomoto Co., Inc.

TNYA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TNYA has been loosely correlated with VCYT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TNYA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNYA
1D Price
Change %
TNYA100%
+4.03%
VCYT - TNYA
40%
Loosely correlated
+1.93%
ABSI - TNYA
33%
Loosely correlated
+3.33%
OPT - TNYA
33%
Loosely correlated
N/A
FATE - TNYA
33%
Poorly correlated
+1.70%
RCUS - TNYA
33%
Poorly correlated
+2.33%
More